Gastrointestinal dysfunction in Parkinson's disease

Summary Our understanding of dysfunction of the gastrointestinal system in patients with Parkinson's disease has increased substantially in the past decade. The entire gastrointestinal tract is affected in these patients, causing complications that range from oral issues, including drooling and...

Full description

Saved in:
Bibliographic Details
Published in:Lancet neurology 2015-06, Vol.14 (6), p.625-639
Main Authors: Fasano, Alfonso, Dr, Visanji, Naomi P, PhD, Liu, Louis W C, MD, Lang, Antony E, Prof, Pfeiffer, Ronald F, Prof
Format: Article
Language:English
Subjects:
Comorbidity
Dopamine
Drug dosages
Gastrointestinal Diseases - complications
Gastrointestinal Diseases - drug therapy
Gastrointestinal Diseases - epidemiology
Humans
Hypotheses
Nervous system
Neurology
Ostomy
Parkinson Disease - drug therapy
Parkinson Disease - epidemiology
Parkinson Disease - etiology
Parkinson's disease
Physiology
Studies
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c500t-996b8c6a0b0861f20ffc7d36972f76ed0a4482afe80419324dac1ea393a255213
cites cdi_FETCH-LOGICAL-c500t-996b8c6a0b0861f20ffc7d36972f76ed0a4482afe80419324dac1ea393a255213
container_end_page 639
container_issue 6
container_start_page 625
container_title Lancet neurology
container_volume 14
creator Fasano, Alfonso, Dr
Visanji, Naomi P, PhD
Liu, Louis W C, MD
Lang, Antony E, Prof
Pfeiffer, Ronald F, Prof
description Summary Our understanding of dysfunction of the gastrointestinal system in patients with Parkinson's disease has increased substantially in the past decade. The entire gastrointestinal tract is affected in these patients, causing complications that range from oral issues, including drooling and swallowing problems, to delays in gastric emptying and constipation. Additionally, small intestinal bacterial overgrowth and Helicobacter pylori infection affect motor fluctuations by interfering with the absorption of antiparkinsonian drugs. The multifaceted role of the gastrointestinal system in Parkinson's disease necessitates a specific and detailed assessment and treatment plan. The presence of pervasive α-synuclein deposition in the gastrointestinal tract strongly implicates this system in the pathogenesis of Parkinson's disease. Future studies elucidating the role of the gastrointestinal tract in the pathological progression of Parkinson's disease might hold potential for early disease detection and development of neuroprotective approaches.
doi_str_mv 10.1016/S1474-4422(15)00007-1
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1697221582</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1474442215000071</els_id><sourcerecordid>3687212441</sourcerecordid><originalsourceid>FETCH-LOGICAL-c500t-996b8c6a0b0861f20ffc7d36972f76ed0a4482afe80419324dac1ea393a255213</originalsourceid><addsrcrecordid>eNqFkMFO3DAQhq2qqFDaRyhaqQfgEOqZ2IlzAVWoLEhIrQScLa8zkQxZBzxJpX17kt1lK3GpL2ONvvns-YX4BvIMJBQ_7kCVKlMK8QT0qRxPmcEHcbBtF_rj7o64Lz4zP0qJoAx8EvuoK1OiwQORzx33qQuxJ-5DdO2sXnEzRN-HLs5CnP1x6SlE7uIxz-rA5Ji-iL3GtUxft_VQPFz9ur-8zm5_z28uf95mXkvZZ1VVLIwvnFxIU0CDsml8WedFVWJTFlRLp5RB15CRCqocVe08kMur3KHWCPmhONl4n1P3Moz_s8vAntrWReoGtjCpELTBEf3-Dn3shjSuM1EGUINWk1BvKJ865kSNfU5h6dLKgrRTqnadqp0is6DtOlU7zR1t7cNiSfVu6i3GEbjYADTG8TdQsuwDRU91SOR7W3fhv0-cvzP4NsTgXftEK-J_21hGKzeSyQF6bYD8FVoxmVU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1681251541</pqid></control><display><type>article</type><title>Gastrointestinal dysfunction in Parkinson's disease</title><source>Elsevier</source><creator>Fasano, Alfonso, Dr ; Visanji, Naomi P, PhD ; Liu, Louis W C, MD ; Lang, Antony E, Prof ; Pfeiffer, Ronald F, Prof</creator><creatorcontrib>Fasano, Alfonso, Dr ; Visanji, Naomi P, PhD ; Liu, Louis W C, MD ; Lang, Antony E, Prof ; Pfeiffer, Ronald F, Prof</creatorcontrib><description>Summary Our understanding of dysfunction of the gastrointestinal system in patients with Parkinson's disease has increased substantially in the past decade. The entire gastrointestinal tract is affected in these patients, causing complications that range from oral issues, including drooling and swallowing problems, to delays in gastric emptying and constipation. Additionally, small intestinal bacterial overgrowth and Helicobacter pylori infection affect motor fluctuations by interfering with the absorption of antiparkinsonian drugs. The multifaceted role of the gastrointestinal system in Parkinson's disease necessitates a specific and detailed assessment and treatment plan. The presence of pervasive α-synuclein deposition in the gastrointestinal tract strongly implicates this system in the pathogenesis of Parkinson's disease. Future studies elucidating the role of the gastrointestinal tract in the pathological progression of Parkinson's disease might hold potential for early disease detection and development of neuroprotective approaches.</description><identifier>ISSN: 1474-4422</identifier><identifier>EISSN: 1474-4465</identifier><identifier>DOI: 10.1016/S1474-4422(15)00007-1</identifier><identifier>PMID: 25987282</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Comorbidity ; Dopamine ; Drug dosages ; Gastrointestinal Diseases - complications ; Gastrointestinal Diseases - drug therapy ; Gastrointestinal Diseases - epidemiology ; Humans ; Hypotheses ; Nervous system ; Neurology ; Ostomy ; Parkinson Disease - drug therapy ; Parkinson Disease - epidemiology ; Parkinson Disease - etiology ; Parkinson's disease ; Physiology ; Studies</subject><ispartof>Lancet neurology, 2015-06, Vol.14 (6), p.625-639</ispartof><rights>Elsevier Ltd</rights><rights>2015 Elsevier Ltd</rights><rights>Copyright © 2015 Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier Limited Jun 2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c500t-996b8c6a0b0861f20ffc7d36972f76ed0a4482afe80419324dac1ea393a255213</citedby><cites>FETCH-LOGICAL-c500t-996b8c6a0b0861f20ffc7d36972f76ed0a4482afe80419324dac1ea393a255213</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25987282$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fasano, Alfonso, Dr</creatorcontrib><creatorcontrib>Visanji, Naomi P, PhD</creatorcontrib><creatorcontrib>Liu, Louis W C, MD</creatorcontrib><creatorcontrib>Lang, Antony E, Prof</creatorcontrib><creatorcontrib>Pfeiffer, Ronald F, Prof</creatorcontrib><title>Gastrointestinal dysfunction in Parkinson's disease</title><title>Lancet neurology</title><addtitle>Lancet Neurol</addtitle><description>Summary Our understanding of dysfunction of the gastrointestinal system in patients with Parkinson's disease has increased substantially in the past decade. The entire gastrointestinal tract is affected in these patients, causing complications that range from oral issues, including drooling and swallowing problems, to delays in gastric emptying and constipation. Additionally, small intestinal bacterial overgrowth and Helicobacter pylori infection affect motor fluctuations by interfering with the absorption of antiparkinsonian drugs. The multifaceted role of the gastrointestinal system in Parkinson's disease necessitates a specific and detailed assessment and treatment plan. The presence of pervasive α-synuclein deposition in the gastrointestinal tract strongly implicates this system in the pathogenesis of Parkinson's disease. Future studies elucidating the role of the gastrointestinal tract in the pathological progression of Parkinson's disease might hold potential for early disease detection and development of neuroprotective approaches.</description><subject>Comorbidity</subject><subject>Dopamine</subject><subject>Drug dosages</subject><subject>Gastrointestinal Diseases - complications</subject><subject>Gastrointestinal Diseases - drug therapy</subject><subject>Gastrointestinal Diseases - epidemiology</subject><subject>Humans</subject><subject>Hypotheses</subject><subject>Nervous system</subject><subject>Neurology</subject><subject>Ostomy</subject><subject>Parkinson Disease - drug therapy</subject><subject>Parkinson Disease - epidemiology</subject><subject>Parkinson Disease - etiology</subject><subject>Parkinson's disease</subject><subject>Physiology</subject><subject>Studies</subject><issn>1474-4422</issn><issn>1474-4465</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqFkMFO3DAQhq2qqFDaRyhaqQfgEOqZ2IlzAVWoLEhIrQScLa8zkQxZBzxJpX17kt1lK3GpL2ONvvns-YX4BvIMJBQ_7kCVKlMK8QT0qRxPmcEHcbBtF_rj7o64Lz4zP0qJoAx8EvuoK1OiwQORzx33qQuxJ-5DdO2sXnEzRN-HLs5CnP1x6SlE7uIxz-rA5Ji-iL3GtUxft_VQPFz9ur-8zm5_z28uf95mXkvZZ1VVLIwvnFxIU0CDsml8WedFVWJTFlRLp5RB15CRCqocVe08kMur3KHWCPmhONl4n1P3Moz_s8vAntrWReoGtjCpELTBEf3-Dn3shjSuM1EGUINWk1BvKJ865kSNfU5h6dLKgrRTqnadqp0is6DtOlU7zR1t7cNiSfVu6i3GEbjYADTG8TdQsuwDRU91SOR7W3fhv0-cvzP4NsTgXftEK-J_21hGKzeSyQF6bYD8FVoxmVU</recordid><startdate>20150601</startdate><enddate>20150601</enddate><creator>Fasano, Alfonso, Dr</creator><creator>Visanji, Naomi P, PhD</creator><creator>Liu, Louis W C, MD</creator><creator>Lang, Antony E, Prof</creator><creator>Pfeiffer, Ronald F, Prof</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20150601</creationdate><title>Gastrointestinal dysfunction in Parkinson's disease</title><author>Fasano, Alfonso, Dr ; Visanji, Naomi P, PhD ; Liu, Louis W C, MD ; Lang, Antony E, Prof ; Pfeiffer, Ronald F, Prof</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c500t-996b8c6a0b0861f20ffc7d36972f76ed0a4482afe80419324dac1ea393a255213</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Comorbidity</topic><topic>Dopamine</topic><topic>Drug dosages</topic><topic>Gastrointestinal Diseases - complications</topic><topic>Gastrointestinal Diseases - drug therapy</topic><topic>Gastrointestinal Diseases - epidemiology</topic><topic>Humans</topic><topic>Hypotheses</topic><topic>Nervous system</topic><topic>Neurology</topic><topic>Ostomy</topic><topic>Parkinson Disease - drug therapy</topic><topic>Parkinson Disease - epidemiology</topic><topic>Parkinson Disease - etiology</topic><topic>Parkinson's disease</topic><topic>Physiology</topic><topic>Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fasano, Alfonso, Dr</creatorcontrib><creatorcontrib>Visanji, Naomi P, PhD</creatorcontrib><creatorcontrib>Liu, Louis W C, MD</creatorcontrib><creatorcontrib>Lang, Antony E, Prof</creatorcontrib><creatorcontrib>Pfeiffer, Ronald F, Prof</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Lancet neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fasano, Alfonso, Dr</au><au>Visanji, Naomi P, PhD</au><au>Liu, Louis W C, MD</au><au>Lang, Antony E, Prof</au><au>Pfeiffer, Ronald F, Prof</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gastrointestinal dysfunction in Parkinson's disease</atitle><jtitle>Lancet neurology</jtitle><addtitle>Lancet Neurol</addtitle><date>2015-06-01</date><risdate>2015</risdate><volume>14</volume><issue>6</issue><spage>625</spage><epage>639</epage><pages>625-639</pages><issn>1474-4422</issn><eissn>1474-4465</eissn><coden>LANCAO</coden><abstract>Summary Our understanding of dysfunction of the gastrointestinal system in patients with Parkinson's disease has increased substantially in the past decade. The entire gastrointestinal tract is affected in these patients, causing complications that range from oral issues, including drooling and swallowing problems, to delays in gastric emptying and constipation. Additionally, small intestinal bacterial overgrowth and Helicobacter pylori infection affect motor fluctuations by interfering with the absorption of antiparkinsonian drugs. The multifaceted role of the gastrointestinal system in Parkinson's disease necessitates a specific and detailed assessment and treatment plan. The presence of pervasive α-synuclein deposition in the gastrointestinal tract strongly implicates this system in the pathogenesis of Parkinson's disease. Future studies elucidating the role of the gastrointestinal tract in the pathological progression of Parkinson's disease might hold potential for early disease detection and development of neuroprotective approaches.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>25987282</pmid><doi>10.1016/S1474-4422(15)00007-1</doi><tpages>15</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1474-4422
ispartof Lancet neurology, 2015-06, Vol.14 (6), p.625-639
issn 1474-4422
1474-4465
language eng
recordid cdi_proquest_miscellaneous_1697221582
source Elsevier
subjects Comorbidity
Dopamine
Drug dosages
Gastrointestinal Diseases - complications
Gastrointestinal Diseases - drug therapy
Gastrointestinal Diseases - epidemiology
Humans
Hypotheses
Nervous system
Neurology
Ostomy
Parkinson Disease - drug therapy
Parkinson Disease - epidemiology
Parkinson Disease - etiology
Parkinson's disease
Physiology
Studies
title Gastrointestinal dysfunction in Parkinson's disease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T15%3A17%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gastrointestinal%20dysfunction%20in%20Parkinson's%20disease&rft.jtitle=Lancet%20neurology&rft.au=Fasano,%20Alfonso,%20Dr&rft.date=2015-06-01&rft.volume=14&rft.issue=6&rft.spage=625&rft.epage=639&rft.pages=625-639&rft.issn=1474-4422&rft.eissn=1474-4465&rft.coden=LANCAO&rft_id=info:doi/10.1016/S1474-4422(15)00007-1&rft_dat=%3Cproquest_cross%3E3687212441%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c500t-996b8c6a0b0861f20ffc7d36972f76ed0a4482afe80419324dac1ea393a255213%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1681251541&rft_id=info:pmid/25987282&rfr_iscdi=true